Nature's Sunshine

NATR

Market cap $299M

Overview Fund Activity

16.96 USD

-0.08

0.47%

At close Updated Sep 12, 4:00 PM EDT

Pre-market

After hours

16.80

-0.16

0.94%

1 day

-0.47%

5 days

-1.97%

1 month

4.18%

3 months

17.37%

6 months

25.44%

Year to date

16.48%

1 year

28%

5 years

31.07%

10 years

40.28%

About: Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.

Employees: 819

Consumer Staples Packaged Foods

0

Funds holding %

of 7,462 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

460% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 5

160% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 20

22% more funds holding

Funds holding: 95 [Q1] → 116 (+21) [Q2]

11% more capital invested

Capital invested by funds: $191M [Q1] → $211M (+$20.4M) [Q2]

4.94% less ownership

Funds ownership: 82.33% [Q1] → 77.39% (-4.94%) [Q2]

33% less funds holding in top 10

Funds holding in top 10: 3 [Q1] → 2 (-1) [Q2]

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

See Fund Rankings

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target

$22

30% upside

Avg. target

$22

30% upside

High target

$22

30% upside

1 analyst rating

1 positive

100%

0 neutral

0%

0 negative

0%

Canaccord Genuity

Susan Anderson

$22

Buy

Maintained

1 Aug 2025

See Analyst Rankings

Financial journalist opinion

Nature's Sunshine: Premium Valuation Without Moats, Sell

Nature's Sunshine is a leading U.S.-based herbal supplement manufacturer founded in 1972, operating a Multi-Level Marketing model. Nature's Sunshine (NATR) is trading at a 16.4x forward P/E, a premium compared to the peer average of 14.2x, and higher than companies like Herbalife (4.1x) and USANA (11.2x). The company's forward revenue growth of 2.8% and mixed EPS outlook do not justify the premium valuation, especially when compared to competitors like LifeVantage, which has a 26.6% CAGR EPS.

Nature's Sunshine: Premium Valuation Without Moats, Sell

The Motley Fool

Nature's Sunshine (NATR) Q2 EPS Up 400%

Nature's Sunshine (NATR) Q2 EPS Up 400%

Nature's Sunshine (NATR) Q2 EPS Up 400%

Nature's Sunshine Products, Inc. (NATR) Q2 2025 Earnings Call Transcript

Nature's Sunshine Products, Inc. (NASDAQ:NATR ) Q2 2025 Earnings Conference Call July 31, 2025 5:00 PM ET Company Participants L. Shane Jones - Executive VP of Finance, CFO & Treasurer Nathan G.

Nature's Sunshine Products, Inc. (NATR) Q2 2025 Earnings Call Transcript

Nature's Sunshine Reports Second Quarter 2025 Results

LEHI, Utah, July 31, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) ("Nature's Sunshine"), a leading manufacturer of high-quality herbal and nutritional supplements, reported financial results for the second quarter ended June 30, 2025.

Nature's Sunshine Reports Second Quarter 2025 Results

Nature's Sunshine Sets Second Quarter 2025 Conference Call for Thursday, July 31, 2025, at 5:00 p.m. ET

LEHI, Utah, July 17, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ: NATR) (Nature's Sunshine), a leading manufacturer of high-quality herbal and nutritional supplements, will conduct a conference call on Thursday, July 31, 2025, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the second quarter ended June 30, 2025. The company will report its financial results in a press release prior to the conference call.

Nature's Sunshine Sets Second Quarter 2025 Conference Call for Thursday, July 31, 2025, at 5:00 p.m. ET

Nature's Sunshine Products, Inc. Announces Pricing of Secondary Public Offering of Common Stock

LEHI, Utah, June 26, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ: NATR) (“Nature's Sunshine” or the “Company”), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the pricing of an underwritten secondary public offering of up to 2,854,607 shares of its common stock to be sold by Fosun Pharma USA, Inc (the “Selling Stockholder”). The shares of common stock are being sold at a price of $12.00 per share. The offering is expected to close on June 27, 2025, subject to customary closing conditions.

Nature's Sunshine Products, Inc. Announces Pricing of Secondary Public Offering of Common Stock

Nature's Sunshine Products, Inc. Announces Launch of Secondary Public Offering of Common Stock

LEHI, Utah, June 25, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ: NATR) (“Nature's Sunshine” or the “Company”), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the launch of an underwritten secondary public offering of up to 2,854,607 shares of its common stock to be sold by Fosun Pharma USA, Inc (the “Selling Stockholder”).

Nature's Sunshine Products, Inc. Announces Launch of Secondary Public Offering of Common Stock

Nature's Sunshine Renews Scholarship Fund with Eccles School of Business

LEHI, Utah, June 09, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR), a leading natural health and wellness company that manufactures high quality herbal and nutritional products, announced the renewal of its scholarship in partnership with the David Eccles School of Business at the University of Utah to support economically disadvantaged students in their education.

Nature's Sunshine Renews Scholarship Fund with Eccles School of Business

Nature's Sunshine Announces Leadership Transition Plan

Board Initiates CEO Search Process Terrence Moorehead to Step Down as President and CEO, Once Successor Appointed Company Reaffirms Full Year 2025 Outlook LEHI, Utah, June 02, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) (“Nature's Sunshine”) (the “Company”), a leading manufacturer of high-quality herbal and nutritional supplements, today announced that Terrence Moorehead has notified the Company's Board of Directors (the “Board”) of his decision to step down as President and Chief Executive Officer, effective upon the appointment of a successor. At that time, Mr.

Nature's Sunshine Announces Leadership Transition Plan

Nature's Sunshine Products, Inc. (NATR) Q1 2025 Earnings Call Transcript

Nature's Sunshine Products, Inc. (NASDAQ:NATR ) Q1 2025 Earnings Conference Call May 6, 2025 5:00 PM ET Company Participants Terrence Moorehead - CEO Shane Jones - CFO Nate Brower - General Counsel Conference Call Participants Brian Holland - Davidson Susan Anderson - Canaccord Genuity Operator Good afternoon, everyone. And thank you for participating in today's conference call to discuss Nature's Sunshine's Financial Results for the First Quarter Ended March 31, 2025.

Nature's Sunshine Products, Inc. (NATR) Q1 2025 Earnings Call Transcript

See News Rankings

Charts implemented using Lightweight Charts™